美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

基因编辑

404.86

+7.011.76%

涨家数：4

跌家数：1

平家数：- -

市盈率：- -

高：417.36

开：392.88

低：383.51

收：397.85

成交量：1,844.97万

成交额：3.37亿

市值：86.21亿

流通市值：79.61亿

数据加载中...

总览新闻资讯

华尔街顶级分析师最新评级报告：美国电话电报公司评级上调

环球市场播报

Editas Medicine, Inc.：预计将在2026年中期提交Edit-401的IND/CTA，计划在2026年年底取得初步的人体概念验证数据

美股夜盘｜AI概念股集体走高，CRISPR Therapeutics涨近8%；无人机概念爆发，Ondas Holdings涨超12%

老虎资讯综合

Editas Medicine, Inc.盘中异动早盘股价大跌7.99%报2.48美元

BUZZ-患者死亡后，美国 FDA 停止关键心脏病试验，Intellia 下跌

Intellia Therapeutics, Inc.盘中异动早盘股价大涨5.65%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4556/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因编辑","latestPrice":404.85526,"timestamp":1763153999999,"preClose":397.84735,"halted":0,"volume":18449748,"delay":0,"changeRate":0.017615,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":7.007904,"latestTime":"11-14 16:00:00 EST","open":392.8798,"high":417.35776,"low":383.51273,"amount":336780763.029706,"amplitude":0.08507,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1763370000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.304548,"peRate":-5.075045,"turnoverRate":0.027658,"increases":4,"decrements":1,"flats":0,"marketCap":8621324720,"floatMarketCap":7960759528},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":417.35776,"amplitude":0.08507,"preClose":397.84735,"low":383.51273,"pbRate":"2.304548","latestPrice":404.85526,"volume":18449748,"delay":0,"open":392.8798,"prevYearClose":376.62552,"prevWeekClose":422.9689,"prevMonthClose":498.041,"prevQuarterClose":525.3247,"fiveDayClose":422.9689,"twentyDayClose":593.3187,"sixtyDayClose":388.5943,"secType":"PLATE","market":"US","turnoverRate":0.027658,"peRate":-5.075045,"marketCap":8621324720,"floatMarketCap":7960759528,"timestamp":1763153999999,"nameCN":"基因编辑"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":4,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582308381","title":"华尔街顶级分析师最新评级报告：美国电话电报公司评级上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2582308381","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582308381?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 23:05","pubTimestamp":1762959900,"startTime":"0","endTime":"0","summary":"华尔街最受关注、且能影响市场走势的研究评级报告现已汇总一处。KeyBanc 银行将美国电话电报公司的评级从 “行业权重” 上调至 “增持”，目标股价定为 30 美元。伯恩斯坦公司首次覆盖辛塔斯公司，给予 “与大盘持平” 评级，目标股价定为 200 美元。该机构认为，辛塔斯是一家 “优质成长型公司”，但当前股价已处于高位。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-11-12/doc-infxemns6034755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NTLA","GRAL","BK4137","BK4503","LU1169589451.USD","LU2506952170.USD","BK4214","BK4588","KMX","BK4556","BK4139","BK4550","IE00BSNM7G36.USD","BK4141","LU1861558580.USD","T","BK4535","BK4215","BHF","QUIK","BK4154","LU0650527681.SGD","FND","LU2506951958.HKD","LU1169590202.USD","ATAT","LU1621768206.USD","LU0175139822.USD","BK4162","BK4200","BK4548","LU0211326839.USD","BK4142","BK4234","BK4507","BK4585","NUVL","BK4534","LU1621768115.EUR","CVNA","LU0823417653.USD","AN","CTAS","OUT","BBWI","LU1571399168.USD","LU1621767810.EUR","PGNY","BK4598","CSR"],"gpt_icon":0},{"id":"1152882042","title":"Editas Medicine, Inc.：预计将在2026年中期提交Edit-401的IND/CTA，计划在2026年年底取得初步的人体概念验证数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1152882042","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152882042?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 20:18","pubTimestamp":1762777090,"startTime":"0","endTime":"0","summary":"Editas Medicine, Inc.：预计将在2026年中期提交Edit-401的IND/CTA，计划在2026年年底取得初步的人体概念验证数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"1194188960","title":"美股夜盘｜AI概念股集体走高，CRISPR Therapeutics涨近8%；无人机概念爆发，Ondas Holdings涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194188960","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194188960?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 09:48","pubTimestamp":1762739300,"startTime":"0","endTime":"0","summary":"11月10日，美股夜盘时段，AI概念股集体走高，CRISPR $Therapeutics$涨近8%，$BigBear.ai$、$SoundHound AI$涨超5%，$Tempus AI$、涨超4%，Hims & Hers Health涨超3%；无人机概念走强，$Ondas$ Holdings涨超12%，$Unusual Machines$涨超7%，$Red Cat$涨近5%，$Archer Aviation$涨超3%；核电股多数走高，$NuScale Power$、Nano Nuclear Energy涨超6%，Centrus Energy、$Lightbridge$涨超5%；量子计算概念股普涨，$D-Wave Quantum$、$Quantum Computing$、$Arqit Quantum$、$SEALSQ Corp$涨超3%；","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"953900b5a33d6c6ce418dd845a2b2226","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1861559042.SGD","BK4585","BK4139","LENZ","LU1861558580.USD","BK4007","BK4611","CRSP","BK4556","BK4539"],"gpt_icon":0},{"id":"2581832009","title":"Editas Medicine, Inc.盘中异动 早盘股价大跌7.99%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581832009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581832009?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 22:30","pubTimestamp":1762525825,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时30分，Editas Medicine, Inc.股票出现异动，股价快速跳水7.99%。截至发稿，该股报2.48美元/股，成交量20.3179万股，换手率0.23%，振幅4.46%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107223025a490887e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107223025a490887e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2581002571","title":"BUZZ-患者死亡后，美国 FDA 停止关键心脏病试验，Intellia 下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2581002571","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581002571?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 19:59","pubTimestamp":1762516751,"startTime":"0","endTime":"0","summary":"BUZZ-患者死亡后，美国 FDA 停止关键心脏病试验，Intellia 下跌11月7日 - ** 基因疗法开发商Intellia TherapeuticsNTLA.O股价盘前下跌29%，至8.76美元** 该公司周四晚些时候表示，在一名患者死于严重的肝脏并发症后，美国食品和药物管理局已暂停其两项主要的基因编辑治疗后期试验** 这两项试验正在研究nexiguran ziclumeran治疗使人衰弱的心脏疾病ATTR淀粉样变性伴有心肌病和遗传性ATTR淀粉样变性伴有多发性神经病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL4T3WJ0YY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4535","BK4139","BK4556","NTLA","LU1861558580.USD","LU1861559042.SGD","BK4585"],"gpt_icon":1},{"id":"2580210732","title":"Intellia Therapeutics, Inc.盘中异动 早盘股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580210732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580210732?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 22:30","pubTimestamp":1762180243,"startTime":"0","endTime":"0","summary":"北京时间2025年11月03日22时30分，Intellia Therapeutics, Inc.股票出现波动，股价快速上涨5.65%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110322304394ec544d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110322304394ec544d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LU1861558580.USD","BK4539","BK4585","BK4007","BK4588","BK4556","BK4535","NTLA","LU1861559042.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}